Results for tag: "Cerdelga"

Cerdelga (eliglustat) is a medication used to treat Gaucher disease, a rare genetic disorder that affects the body's ability to break down and store fat. It is a type of endocrine and metabolic disorder drug, which are medications used to treat a variety of conditions related to hormones and metabolism. Cerdelga works by inhibiting the enzyme responsible for breaking down certain fats, which helps to reduce the amount of fat stored in the body. Cerdelga is the only approved treatment for Gaucher disease in the United States and is available in both oral and intravenous forms. It is also approved in several other countries, including the United Kingdom, France, Germany, and Canada. The drug is manufactured by Sanofi Genzyme, a subsidiary of Sanofi, and is marketed in the United States by Genzyme Corporation. The Cerdelga market is highly competitive, with several other companies offering similar treatments for Gaucher disease. These include Shire, Pfizer, and Novartis. Additionally, several generic versions of Cerdelga are available in some countries. Show Less Read more